Patents Assigned to Vibliome Therapeutics, LLC
  • HipK4 inhibitors and uses thereof
    Patent number: 11629143
    Abstract: Provided herein are protein kinase inhibitors, which, in one aspect are selective inhibitors of HipK4. Pharmaceutical compositions and medical uses for the disclosed inhibitors are also provided.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: April 18, 2023
    Assignee: VIBLIOME THERAPEUTICS, LLC
    Inventors: Gary A. Flynn, Ashok Bajji, Khoi Huynh
  • HIPK INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20220177891
    Abstract: Method of treating cancer, such as a metastatic cancer, with inhibitors of homeodomain interacting protein kinase 4 (HIPK4) are provided. Related therapeutic compositions are also disclosed.
    Type: Application
    Filed: February 19, 2020
    Publication date: June 9, 2022
    Applicants: Board of Regents, The University of Texas System, Vibliome Therapeutics, LLC
    Inventors: Qiang SHEN, Gary A. FLYNN